International Journal of Drug Policy

(The median citation count of International Journal of Drug Policy is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-08-01 to 2023-08-01.)
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis326
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets101
Tackling the overdose crisis: The role of safe supply93
An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples92
“Everything is not right anymore”: Buprenorphine experiences in an era of illicit fentanyl76
Fentanyl shock: The changing geography of overdose in the United States74
Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study71
Safer opioid distribution in response to the COVID-19 pandemic68
Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada67
Kratom policy: The challenge of balancing therapeutic potential with public safety67
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada65
COVID-19 and the health of people who use drugs: What is and what could be?61
Syringe services program (SSP) operational changes during the COVID-19 global outbreak60
Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites59
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?56
Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky53
The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis52
Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern51
Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs51
Ambiguous identities of drugs and people: A scoping review of opioid-related stigma49
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update48
The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England48
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-1948
“We don’t got that kind of time, man. We’re trying to get high!”: Exploring potential use of drug checking technologies among structurally vulnerable people who use drugs47
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System47
Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston47
Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets45
Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review44
An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods44
COVID-19 - Enacting a ‘new normal’ for people who use drugs44
“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine use in a time of treatment expansion43
Prescription drug monitoring programs operational characteristics and fatal heroin poisoning43
“Someone who is in this thing that I am suffering from”: The role of peers and other facilitators for task sharing substance use treatment in South African HIV care42
“You are not clean until you're not on anything”: Perceptions of medication-assisted treatment in rural Appalachia41
‘It's too much, I'm getting really tired of it’: Overdose response and structural vulnerabilities among harm reduction workers in community settings41
The value of unsolicited online data in drug policy research41
Syringe services programs: An examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S.41
Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic41
Comparing Canadian and United States opioid agonist therapy policies41
Access to cannabidiol without a prescription: A cross-country comparison and analysis40
Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States39
Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology39
Narrative identity, rationality, and microdosing classic psychedelics38
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”38
Doing ontopolitically-oriented research: Synthesising concepts from the ontological turn for alcohol and other drug research and other social sciences38
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences37
The epidemiology of drug use disorders cross-nationally: Findings from the WHO’s World Mental Health Surveys36
Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States36
Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all36
Microdosing psychedelics: Motivations, subjective effects and harm reduction36
Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting35
Evaluation of a drug checking service at a large scale electronic music festival in Portugal35
Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use35
Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA35
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-1934
Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis34
Changes in characteristics of drug overdose death trends during the COVID-19 pandemic34
‘It's our safe sanctuary’: Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario34
Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market34
Known fentanyl use among clients of harm reduction sites in British Columbia, Canada34
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework34
Adverse drug-related effects among electronic dance music party attendees33
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-1933
“That's why people don't call 911”: Ending routine police attendance at drug overdoses33
Drugs as technologies of the self: Enhancement and transformation in LGBTQ cultures32
Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs32
Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs32
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study32
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis32
“How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic31
Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs31
Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs31
Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States30
Quantitative evaluation of an integrated nurse model of care providing hepatitis C treatment to people attending homeless services in Melbourne, Australia30
Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone30
Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England30
Sellers’ risk perceptions in public and private social media drug markets30
Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley30
Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study29
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain29
Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals28
Intentions, actions and outcomes: A follow up survey on harm reduction practices after using an English festival drug checking service28
From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic28
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada28
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants27
A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people27
“Bed Bugs and Beyond”: An ethnographic analysis of North America's first women-only supervised drug consumption site27
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs26
Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States26
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 201926
Delineation of chemsex patterns of men who have sex with men in association with their sexual networks and linkage to HIV prevention26
“It's like super structural” – Overdose experiences of youth who use drugs and police in three non-metropolitan cities across British Columbia26
Engagement with medical cannabis information from online and mass media sources: Is it related to medical cannabis attitudes and support for legalization?25
The perfect storm: COVID-19, mass incarceration and the opioid epidemic25
Race, cannabis and the Canadian war on drugs: An examination of cannabis arrest data by race in five cities25
Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis25
International differences in patterns of cannabis use among adult cigarette smokers: Findings from the 2018 ITC Four Country Smoking and Vaping Survey25
Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: A systematic review25
High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units25
Framing and scientific uncertainty in nicotine vaping product regulation: An examination of competing narratives among health and medical organisations in the UK, Australia and New Zealand25
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic25
Prevalence, frequency, and motivations for alkyl nitrite use among gay, bisexual and other men who have sex with men in Australia25
Housing in crisis: A qualitative study of the socio-legal contexts of residential evictions in Vancouver’s Downtown Eastside25
Rural risk environments for hepatitis c among young adults in appalachian kentucky25
Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective24
Police-related barriers to harm reduction linked to non-fatal overdose amongst sex workers who use drugs: Results of a community-based cohort in Metro Vancouver, Canada24
The impact of cannabis legalization in Uruguay on adolescent cannabis use24
No “back to normal” after COVID-19 for our failed drug policies24
The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic24
Attitudes toward legalization of marijuana in the United States, 1986-2016: Changes in determinants of public opinion24
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study24
Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs24
Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama24
Overdose among mothers: The association between child removal and unintentional drug overdose in a longitudinal cohort of marginalised women in Canada24
Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey24
Recent fentanyl use among people who inject drugs: Results from a rapid assessment in Baltimore, Maryland23
Subgroup trends in alcohol and cannabis co-use and related harms during the rollout of recreational cannabis legalization in Washington state23
Injecting drug use during sex (known as “slamming”) among men who have sex with men: Results from a time-location sampling survey conducted in five cities, France23
Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program23
Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products23
A qualitative study of e-cigarette emergence and the potential for renormalisation of smoking in UK youth23
Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies23
Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada23
Price and product variation in Washington's recreational cannabis market22
Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia22
Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use22
Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors22
Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives22
When does the cutting of cocaine and heroin occur? The first large-scale study based on the chemical analysis of cocaine and heroin seizures in Switzerland22
Is South Africa being spared the global opioid crisis? A review of trends in drug treatment demand for heroin, nyaope and codeine-related medicines in South Africa (2012–2017)22
MDMA-related deaths in Australia 2000 to 201822
People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky22
Re-configured pleasures: How young people feel good through abstaining or moderating their drinking22
“It's an emotional roller coaster… But sometimes it's fucking awesome”: Meaning and motivation of work for peers in overdose response environments in British Columbia22
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom22
The protective effect of trusted dealers against opioid overdose in the U.S.22
Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting21
Drugs, discipline and death: Causes and predictors of mortality among people who inject drugs in Tijuana, 2011–201821
Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis21
Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland21
‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work21
Drugs and drug wars as populist tropes in Asia: Illustrative examples and implications for drug policy21
“I couldn't live with killing one of my friends or anybody”: A rapid ethnographic study of drug sellers’ use of drug checking21
Adulterants and altruism: A qualitative investigation of “drug checkers” in North America21
HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C21
Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers21
Preliminary findings of the impact of COVID-19 on drugs crypto markets21
Divergences and commonalities between the US opioid crisis and prescription medicine mis/use in West Africa20
Stigma, discrimination and crystal methamphetamine (‘ice’): Current attitudes in Australia20
How high: Differences in the developments of cannabis markets in two legalized states20
Changes in alcohol and cigarette consumption in response to medical and recreational cannabis legalization: Evidence from U.S. state tax receipt data20
The Dark Web and cannabis use in the United States: Evidence from a big data research design20
Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data20
Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs20
The internet market for Kratom, an opioid alternative and variably legal recreational drug20
Good Samaritan laws and overdose mortality in the United States in the fentanyl era20
Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets20
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects20
Perceptions of effectiveness and believability of pictorial and text-only health warning labels for cannabis products among Canadian youth20
Trajectories of retention in opioid agonist therapy in a Canadian setting20
The impact of rurality on opioid-related harms: A systematic review of qualitative research20
“I probably got a minute”: Perceptions of fentanyl test strip use among people who use stimulants20
The impacts of potency, warning messages, and price on preferences for Cannabis flower products20
Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project19
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids19
Producing the vulnerable subject in English drug policy19
No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions19
Fentanyl panic goes viral: The spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media19
The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs19
Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department19
Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?19
Pleasure and HIV biomedical discourse: The structuring of sexual and drug-related risks for gay and bisexual men who Party-n-Play19
Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington19
“Doing What Is Right and Doing It Right”: A Mapping Review of Athletes' Perception of Anti-Doping Legitimacy19
Digital chemsex support and care: The potential of just-in-time adaptive interventions18
Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast18
Individual and network factors associated with HCV treatment uptake among people who inject drugs18
Triangulating web & general population surveys: Do results match legal cannabis market sales?18
Intensity of cannabis use: Findings from three online surveys18
Alcohol policy has saved lives in the Russian Federation18
Content analysis of online product descriptions from cannabis retailers in six US states18
Receiving addiction treatment in the US: Do patient demographics, drug of choice, or substance use disorder severity matter?18
Portable gas chromatography–mass spectrometry in drug checking: Detection of carfentanil and etizolam in expected opioid samples18
“Everybody living with a chronic disease is entitled to be cured”: Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drug18
Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking18
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram18
One “chemsex” or many? Types of chemsex sessions among gay and other men who have sex with men in Madrid, Spain: findings from a qualitative study17
“Towards eliminating viral hepatitis”: Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination17
Enacting ‘more-than-human’ care: Clients’ and counsellors’ views on the multiple affordances of chatbots in alcohol and other drug counselling17
Between gang talk and prohibition: The transfer of blame for County Lines17
Digital figurations in the online trade of illicit drugs: A qualitative content analysis of darknet forums17
The effectiveness of drug-related Good Samaritan laws: A review of the literature17
“Another thing to live for”: Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities17
Legitimizing and negotiating abstinence: Young adults’ narratives about practicing situational and long term abstinence in Denmark.17
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study17
Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers17
Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research17
Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services17
Should we smoke it for you as well? An ethnographic analysis of a drug cryptomarket environment17
Government monopoly as an instrument for public health and welfare: Lessons for cannabis from experience with alcohol monopolies17
Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, Canada17
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence16
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minima16
‘It’s good being part of the community and doing the right thing’: (Re)problematising ‘community’ in new recovery-oriented policy and consumer accounts16
Legal cannabis market shares during Canada's first year of recreational legalisation16
A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment16
Tough Tradeoffs: Coca crops and agrarian alternatives in Colombia16
Help me fix: The provision of injection assistance at an unsanctioned overdose prevention site in Toronto, Canada16
Peer-delivered services for substance use in low- and middle-income countries: A systematic review16
Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs16
Alcohol consumption and attributable harm in middle-income South-East Asian countries: Epidemiology and policy options16
Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-1915
A systematic review of cigarette smoking trajectories in adolescents15
Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Aust15
Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination15
The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review15
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs15
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States15
“Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs15
Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in Canada15
Producing the ‘problem’ of new psychoactive substances (NPS) in English prisons15
Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market15
Connections built and broken: The ontologies of relapse15
The Pat Jasan drug eradication social movement in Northern Myanmar, part one: Origins & reactions15
Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE)15
Message framing to reduce stigma and increase support for policies to improve the wellbeing of people with prior drug convictions15
Alcohol policy in Iran: Policy content analysis15
Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations15
What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada15
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Ca15
Critical studies of harm reduction: Overdose response in uncertain political times15
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures15
Testing the boundaries: Self-medicated testosterone replacement and why it is practised14
Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care14
Leveraging crowdsourcing methods to collect qualitative data in addiction science: Narratives of non-medical prescription opioid, heroin, and fentanyl use14
Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex14
Unity in diversity: A systematic review on the GHB using population14
Extended lockdown and India’s alcohol policy: a qualitative analysis of newspaper articles14
Sources of cannabis among young adults and associations with cannabis-related outcomes14
Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting14
‘I feel like I have to become part of that identity’: Negotiating femininities and friendships through alcohol consumption in Newcastle, UK14
More-than-harm reduction: Engaging with alternative ontologies of ‘movement’ in UK drug services14
Possibilities and pitfalls? Moderate drinking and alcohol abstinence at home since the COVID-19 lockdown14
A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons14
Consumer protection in drug policy: The human rights case for safe supply as an element of harm reduction14
Public support for alcohol control initiatives across seven countries14
The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevity14
Can google trends search inform us about the population response and public health impact of abrupt change in alcohol policy? A case study from India during the covid-19 pandemic14
What is the face of new nicotine users? 2012–2018 e-cigarettes and tobacco use among young students in Italy14
The effect of cannabis laws on opioid use14
Monitoring new psychoactive substances: Exploring the contribution of an online discussion forum14
We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers14
Frequency of injecting among people who inject drugs: A systematic review and meta-analysis14
Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina14
Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study14
The effects of the iPlayClean education programme on doping attitudes and susceptibility to use banned substances among high-level adolescent athletes from the UK: A cluster-randomised controlled tria14
Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand?13
Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders13
Structural competency in the post-prison period for people who inject drugs: A qualitative case study13
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran13
Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data13
Pharmacist dispensed naloxone: Knowledge, availability, participation and cost in selected California counties13
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort13
“You don’t have to squirrel away in a staircase”: Patient motivations for attending a novel supervised drug consumption service in acute care13
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months13
Frequently asked questions about dabbing concentrates in online cannabis community discussion forums13
Effects of strengthening alcohol labels on attention, message processing, and perceived effectiveness: A quasi-experimental study in Yukon, Canada13
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply13
Alcohol and drinking within the lives of midlife women: A meta-study systematic review13
Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis13
Designing drunkenness: How pubs, bars and nightclubs increase alcohol sales13
Identifying opportunities for engaging the ‘community’ in local alcohol decision-making: A literature review and synthesis13
Carfentanil on the darknet: Potential scam or alarming public health threat?13
Uruguayan Cannabis Social Clubs: From activism to dispensaries?13
Growing pains: An overview of cannabis quality control and quality assurance in Canada13
A qualitative study of a publicly funded pharmacy-dispensed naloxone program13
What explains the decline in adolescent binge-drinking in New Zealand?12
Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets12
Trends in cannabis use among U.S. adults amid the COVID-19 pandemic12
Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic–Is an update of legal restrictions warranted?12
How medical are states’ medical cannabis policies?: Proposing a standardized scale12
The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use12
The use of multi-national web surveys for comparative analysis: Lessons from the European Web Survey on Drugs12
‘Social health’, ‘physical health’, and well-being: Analysing with bourdieusian concepts the interplay between the practices of heavy drinking and exercise among young people12
Understanding the reasons for using methamphetamine by sexual minority people in Dhaka, Bangladesh12
Rethinking enhancement substance use: A critical discourse studies approach12
Investigating opioid preference to inform safe supply services: A cross sectional study12
A normalised future of addiction12
Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors12
Urban, individuals of color are impacted by fentanyl-contaminated heroin12
The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada12
Beyond the narco frontier; rethinking an imaginary of the margins12
Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis12
The effect of injecting alone on the use of drug checking services among people who inject drugs12
Factors associated with methamphetamine dependency among men who have sex with men engaging in chemsex: Findings from the COMeT study in Taiwan12
Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia12
Operational and contextual barriers to accessing supervised consumption services in two Canadian cities12
Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks12
Precarity, poverty and poppy: Encountering development in the uplands of Shan State, Myanmar12
How to think with models and targets: Hepatitis C elimination as a numbering performance12
#studydrugs–Persuasive posting on Instagram12
A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage12
Evidence that social-economic factors play an important role in drug overdose deaths12
The prevalence and factors associated with smoking among lesbian and bisexual women: Analysis of the Australian National Drug Strategy Household Survey12
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy12
Challenges and opportunities for greater tobacco control in Japan12
Critical realism and the ‘ontological politics of drug policy’12
Predictors of work engagement among Australian non-government drug and alcohol employees: Implications for policy and practice12
Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics12
Simple possession as a ‘tool’: Drug law enforcement practices among police officers in the context of depenalization in British Columbia, Canada12
The substitution program on trial: progress and setbacks of the peace agreement in the policy against illicit crops in Colombia12
Challenges of providing COVID-19 prevention services to homeless people who use drugs in Iran11
Perceived vulnerability to overdose-related arrests among people who use drugs in Maryland11
The Philippines’ antidrug campaign: Spatial and temporal patterns of killings linked to drugs11
Overview of “home” cultivation policies and the case for community-based cannabis supply11
Effectiveness of a school-based substance use prevention program taught by police officers in Brazil: Two cluster randomized controlled trials of the PROERD11
Hospital policy as a harm reduction intervention for people who use drugs11
A policy mapping analysis of goals, target populations, and punitive notions in the U.S. congressional response to the opioid epidemic11
Pharmacosex: Reimagining sex, drugs and enhancement11
Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis11
Drug overdose mortality among stateside Puerto Ricans: Evidence of a health disparity11
The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation11
Beyond a ‘post-cure’ world: Sketches for a new futurology of hepatitis C11
Visitors of the Dutch drug checking services: Profile and drug use experience11
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing11
Opioids, stimulants, and depressant drugs in fifteen Mexican Cities: A wastewater-based epidemiological study11
A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada11
Medicinal cannabis and driving: the intersection of health and road safety policy11
Examining the implementation of police-assisted referral programs for substance use disorder services in Massachusetts11
Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin11
Trajectories of alcohol use problems based on early adolescent alcohol use: Findings from a 35 year population cohort11
Uncertainty and risk: A framework for understanding pricing in online drug markets11
Association of alcohol control policies with adolescent alcohol consumption and with social inequality in adolescent alcohol consumption: A multilevel study in 33 countries and regions11
E-cigarette use is associated with susceptibility to tobacco use among Australian young adults11
Drug induced homicide laws may worsen opioid related harms: An example from rural North Carolina11
Taking opioids in times of crisis: Institutional oversight, chronic pain and suffering in an integrated healthcare delivery system in the U.S.11
Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting11
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada11
Self-reported driving after marijuana use in association with medical and recreational marijuana policies11
A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic11
Problematic alcohol use among fathers in Kenya: Poverty, people, and practices as barriers and facilitators to help acceptance11
Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy11
Attitudes towards Kratom use, decriminalization and the development of a community-based Kratom control mechanism in Southern Thailand11
Co-creating a social science research agenda for clean sport: An international Delphi study11
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis11
Seeking legitimacy for broad understandings of substance use11
Risk and enabling environments in sport: Systematic doping as harm reduction11
Analytical findings in used syringes from a syringe exchange program11
Prevalence and correlates of amphetamine-type stimulant use among transgender women in Cambodia10
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence10
Towards an ontological politics of drug policy: Intervening through policy, evidence and method10
No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic10
US drug overdose mortality: 2009–2018 increases affect young people who use drugs10
Poppers, queer sex and a Canadian crackdown: Examining the experiences of alkyl nitrite use among young sexual minority men10
Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: A gender-based analysis10
Trends in opioid-related crime incidents and comparison with opioid overdose outcomes in the United States10
Critical policy frontiers: The drugs-development-peacebuilding trilemma10
The success rate of online illicit drug transactions during a global pandemic10
A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia10
Not what the doctor ordered: Motivations for nonmedical prescription drug use among people who use illegal drugs10
Compulsory and voluntary drug treatment models in China: A need for improved evidence-based policy and practice to reduce the loaded burden of substance use disorders10
Service providers’ perceptions of barriers to the implementation of trauma-focused substance use services for women in Cape Town, South Africa10
Perceived Importance of Factors in Cannabis Purchase Decisions: A Best-worst Scaling Experiment10
Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex10
Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose10
‘I could have went down a different path’: Talking to people who used drugs problematically and service providers about Irish drug policy alternatives10
“You need to just provide health services:” navigating the politics of harm reduction in the twin housing and overdose crises in Vancouver, BC10
Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions10
Reinfection in a large cohort of prison inmates with sustained virological response after treatment of chronic hepatitis C in Catalonia (Spain), 2002–201610
Latent patterns of polysubstance use among people who use opioids: A systematic review10
An examination of the role of changes in country-level leisure time internet use and computer gaming on adolescent drinking in 33 European countries10
“Is it banned? Is it illegal?”: Navigating Western Australia's regulatory environment for e-cigarettes10
Perceptions of cannabis health information labels among people who use cannabis in the U.S. and Canada10
Evidence-making hepatitis C cure: Towards a science that knows more carefully10
Naloxone distribution, trauma, and supporting community-based overdose responders10
‘Vaping and fidget-spinners’: A qualitative, longitudinal study of e-cigarettes in adolescence10
How the U.S.-Mexico border influences adolescent substance use: Youth participatory action research using photovoice10
The impact of deportation policies on the substance using behaviors of US-citizen Latinos10
“You can't go wrong being safe”: Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs10
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway10
The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada10
Suitability of infrared spectroscopy for drug checking in harm reduction centres9
COVID-19 risks among people who inject drugs in Puerto Rico9
‘What makes up wine o'clock? Understanding social practices involved in alcohol use among women aged 40–65 years in Australia9
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006–20209
Characterizing stimulant overdose: A qualitative study on perceptions and experiences of “overamping”9
Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study9
Police officers’ knowledge, understanding and implementation of the Good Samaritan Drug Overdose Act in BC, Canada9
Predictors of using social media to purchase drugs in New Zealand: Findings from a large-scale online survey9
Syringe access and health harms: Characterizing “landscapes of antagonism” in California's Central Valley9
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing9
Sisters are never alike? Drug control intensity in the Nordic countries9
Progress of smoke-free policy adoption at district level in Indonesia: A policy diffusion study9
Service provision and barriers to care for men who have sex with men engaging in chemsex and sexualised drug use in England9
Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis9
From prohibition to regulation: A comparative analysis of the emergence and related outcomes of new legal cannabis policy models (Colorado, Washington State and Uruguay)9
The emerging norms of e-cigarette use among adolescents: A meta-ethnography of qualitative evidence9
‘Small communities, large oversight’: The impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada9
Reductions in alcohol use following medical cannabis initiation: results from a large cross-sectional survey of medical cannabis patients in Canada9
The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population: Markets, content and user harms9
Complex cases – Complex representations of problems9
Associations with drug use and sexualised drug use among women who have sex with women (WSW) in the UK: Findings from the LGBT Sex and Lifestyles Survey9
Hey Google! will New Zealand vote to legalise cannabis? Using Google Trends data to predict the outcome of the 2020 New Zealand cannabis referendum9
Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions9
‘Synthetic cannabis’: A dangerous misnomer9
High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs9
Making legitimacy: Drug user representation in United Nations drug policy settings9
Drinking to excess and the tipping point: An international study of alcohol intoxication in 61,000 people9
Decision-making by laypersons equipped with an emergency response smartphone app for opioid overdose9
A national case fatality study of drugs taken in intentional overdose9
Image and performance enhancing drug use among men who have sex with men and women who have sex with women in the UK9
A descriptive study of racial and ethnic differences of drug overdoses and naloxone administration in Pennsylvania9
Reliable drug war data: The Consolidated Counterdrug Database and cocaine interdiction in the “Transit Zone”9
Understanding rural risk environments for drug-related harms: Progress, challenges, and steps forward9
What is a rural opioid risk and policy environment?9
A review of the evidence on cigarettes with reduced addictiveness potential9
Pathways to ‘recovery’ and social reintegration: The experiences of long-term clients of methadone maintenance treatment in an Irish drug treatment setting8
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids8
‘Potential issues of morbidity, toxicity and dependence’: Problematizing the up-scheduling of over-the-counter codeine in Australia8
Lessons learned recruiting a diverse sample of rural study participants during the COVID-19 pandemic8
Problematisations in drug use policy, practice and research8
Effects of messaging on public support for drug consumption rooms in scotland, UK8
The introduction of fentanyl on the US–Mexico border: An ethnographic account triangulated with drug checking data from Tijuana8
Steps toward a theory of place effects on drug use: Risk, marginality, and opportunity in small and remote California towns8
Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study8
Fentanyl self-testing in a community-based sample of people who inject drugs, San Francisco8
Youth drinking in decline: What are the implications for public health, public policy and public debate?8
Drivers of opioid use in Appalachian Pennsylvania: Cross-cutting social and community-level factors8
A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison8
Being ‘in place’, being ‘out of place’: Problematising marginalised drug users in two cities8
‘We're in this together’: A content analysis of marketing by alcohol brands on Facebook and Instagram during the first UK Lockdown, 20208
The movement and translation of drug policy ideas: The case of ‘new recovery’8
The harms of punishing substance use during pregnancy8
Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C virus infection in Vancouver, Canada8
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot8
The perspectives of people who use drugs regarding short term involuntary substance use care for severe substance use disorders8
Young people's use of e-cigarettes in Wales, England and Scotland before and after introduction of EU Tobacco Products Directive regulations: a mixed-method natural experimental evaluation8
Drinking comfortably? Gender and affect among Danish pre-partiers8
A review of network simulation models of hepatitis C virus and HIV among people who inject drugs8
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island8
Ontological journeys: The lifeworld of opium across the Afghan-Iranian border in/out of the pharmacy8
Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study.8
“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison8
Trajectories of initiation for the heroin-based drug whoonga – qualitative evidence from South Africa8
Making sense of ‘‘drink responsibly’’ messages: Explorations of the understanding and interpretations of young Nigerians who use alcohol8
Examining reactions to smoking and COVID-19 risk messages: An experimental study with people who smoke8
Applying the capability, opportunity, motivation, and behavior model to identify opportunities to increase pharmacist comfort dispensing naloxone in Texas: A structural equation modeling approach8
Recreational drug use and use of drugs associated with chemsex among HIV-negative and HIV-positive heterosexual men and women attending sexual health and HIV clinics in England8
Conceptualizing overdose trauma: The relationships between experiencing and witnessing overdoses with PTSD symptoms among street-recruited female sex workers in Baltimore, Maryland8
Diversity in addiction publishing8
“One guy goes to jail, two people are ready to take his spot”: Perspectives on drug-induced homicide laws among incarcerated individuals8
A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island8
Preventing transitions into injection drug use: A call for gender-responsive upstream prevention8
Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey8
The impact of legislation on acute synthetic cannabinoid harms resulting in ambulance attendance8
An evidence synthesis of strategies, enablers and barriers for keeping secrets online regarding the procurement and supply of illicit drugs8
Deconstructing prohibitionist ideology: A sociocognitive approach to understand opinions on UK drug policy and the law8
Use of promethazine, gabapentin and clonidine in combination with opioids or opioid agonist therapies among individuals attending a syringe service program7
Pharmacies and features of the built environment associated with opioid overdose: A geospatial comparison of rural and urban regions in Alabama, USA7
A multi criteria decision analysis (MCDA) for evaluating and appraising government policy responses to non medical heroin use7
Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal7
Pre-exposure prophylaxis (PrEP) uptake and adherence experiences of gay and bisexual men who engage in chemsex: A qualitative study7
Narratives of people who inject drugs on factors contributing to opioid overdose7
Network measures of advice-seeking and resource sharing are related to well-being in recovery homes7
Care, agency and criminality: Making sense of authorised extended distribution in the accounts of key stakeholders7
New psychoactive substance use as a survival strategy in rural marginalised communities in Hungary7
Alarming increase in poisonings from recreational nitrous oxide use after a change in EU-legislation, inquiries to the Dutch Poisons Information Center7
Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky7
Does the gateway theory justify a ban on nicotine vaping in Australia?7
Effects of changes to the taxation of beer on alcohol consumption and government revenue in Australia7
2,4 dinitrophenol: It's not just for men7
Enhancement motivations for using prescription drugs among young adults in Nigeria7
The ever-changing narrative: Supervised injection site policy making in Ontario, Canada7
“It's a revolving door”: Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success7
Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain7
The Pat Jasan drug eradication social movement in northern Myanmar, part two: Deep culture & cultural psychology7
HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study7
Assembling and diversifying social contexts of recovery7
Issues in the establishment of a therapeutic cannabis market under Jamaica's Dangerous Drugs Amendment Act 20157
“With a PICC line, you never miss”: The role of peripherally inserted central catheters in hospital care for people living with HIV/HCV who use drugs7
Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C elimination7
Supplying synthetic opioids during a pandemic: An early look at North America7
Cocalero women and peace policies in Colombia7
Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness model7
Positive effects of community attachment on internalised stigma and wellbeing among people who inject drugs7
Cannabis use and mental health among young sexual and gender minority men: A qualitative study7
Exploring the role of trauma in underpinning sexualised drug use (‘chemsex’) among gay, bisexual and other men who have sex with men in Singapore7
Estimating the size of crack cocaine users in France: Methods for an elusive population with high heterogeneity7
COVID-19 and people who use drugs; seizing opportunity in times of chaos7
Psychedelic-assisted therapies: The past, and the need to move forward responsibly7
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation7
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting7
‘Whatever we have, we owe it to coca’. Insights on armed conflict and the coca economy from Argelia, Colombia7
Community-Based Assessment and Treatment of Hepatitis C Virus-Related Liver Disease, Injecting Drug and Alcohol Use Amongst People Who Are Homeless: A Systematic Review and Meta-Analysis7
“How do online and offline sampling compare in a multinational study of drug use and nightlife behaviour?”7
The hepatitis C care cascade among people who inject drugs accessing harm reduction services in Catalonia: Major gaps for migrants7
Methadone maintenance treatment is swapping one drug for another, and that's why it works: Towards a treatment-based critique of the war on drugs7
Twitter discourse on nicotine as potential prophylactic or therapeutic for COVID-197
Factors associated with state legislators’ support for opioid use disorder parity laws7
‘The opportunity to have their say’? Identifying mechanisms of community engagement in local alcohol decision-making7